Drugs Made In America Acquisition II Corp. (DMII)
10.22
+0.02
(+0.15%)
USD |
NASDAQ |
Nov 04, 16:00
Drugs Made In America Acquisition II Total Assets (Quarterly) : 514.10M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 514.10M |
| March 31, 2026 | 509.73M |
| December 31, 2025 | 504.96M |
| Date | Value |
|---|---|
| September 30, 2025 | 501.01M |
| June 30, 2025 | 0.1134M |
| March 31, 2025 | 0.1051M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Acme United Corp. | 207.86M |
| American Shared Hospital Services | 52.49M |
| Avalon Holdings Corp. | 87.62M |
| Flanigan's Enterprises, Inc. | 157.53M |
| Bar Harbor Bankshares | 4.704B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.14M |
| Shareholders Equity (Quarterly) | 495.96M |
| Debt to Equity Ratio | 0.0009 |
| Current Ratio | 0.3379 |
| Net Debt Paydown Yield | -0.01% |